Aditxt, Inc. (NASDAQ:ADTX) Sees Large Decline in Short Interest

Aditxt, Inc. (NASDAQ:ADTX) was the recipient of a significant decline in short interest in December. As of December 15th, there was short interest totaling 86,655 shares, a decline of 31.2% from the November 30th total of 125,952 shares. Approximately 11.9% of the company’s stock are short sold. Based on an average daily volume of 940,286 shares, the short-interest ratio is presently 0.1 days. Based on an average daily volume of 940,286 shares, the short-interest ratio is presently 0.1 days. Approximately 11.9% of the company’s stock are short sold.

Aditxt Stock Performance

ADTX stock opened at $0.91 on Wednesday. The company’s 50 day moving average price is $5.77 and its 200 day moving average price is $77.55. The firm has a market capitalization of $666,525.80, a price-to-earnings ratio of 0.00 and a beta of 1.43. Aditxt has a fifty-two week low of $0.88 and a fifty-two week high of $6,412.75.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Aditxt in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has an average rating of “Sell”.

About Aditxt

Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.

The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.